Navigation Links
Study finds that tobacco companies changed design of cigarettes without alerting smokers
Date:6/19/2009

Boston, MA -- As President Obama prepares to sign a bill giving the Food and Drug Administration (FDA) oversight of the tobacco industry, a new study from Harvard School of Public Health (HSPH) researchers shows that tobacco manufacturers have continually changed the ingredients and the design of their cigarettes over time, even if those changes have exceeded acceptable product variance guidelines. The result, say the researchers, is that consumers who buy the same brand of product are not made aware of how that product has been altered and what effect those alterations might have on their levels of addiction or harm.

"I hope the FDA requires disclosure of any changes made to tobacco products and that the changes are disallowed if shown to increase appeal, addiction and harm," said Greg Connolly, director of the Tobacco Control Research Program at HSPH.

The study appears in the "Online First" section of the Journal of Tobacco Control and will appear in an upcoming print issue of the journal.

For their study, Connolly and lead author Geoffrey Ferris Wayne, an HSPH researcher, studied internal tobacco company documents released following the 1998 Master Settlement Agreement. These documents describe significant changes made to commercial products over time, including blend, processing, casing, flavoring and physical design features. For example, new methods were developed to process tobacco, altering the smoke chemistry and the form of nicotine delivery, and the levels of processed tobaccos were regularly adjusted within brands.

Despite the constant innovation of tobacco products, which in many cases have exceeded the levels of acceptable variance established within the tobacco industry, for the most part, these changes were not disclosed to consumers, say the researchers.

"Even incremental changes that occur over a period of years can result in significant design differences. The resulting product may have altered chemistry or delivery, yet the smoker is largely unaware of these changes. This underscores the need for industry transparency and accountability," said Ferris Wayne.

The study builds on earlier research done at HSPH on how products are designed to enhance appeal and addiction. At Senate hearings on the FDA bill last year, Connolly discussed that research, including how tobacco companies have increased nicotine content over time, manipulated menthol and added candy-like flavors to enhance appeal to children.

Until regulators have a system in place for assessing product revisions, Connolly and Ferris Wayne advise that all changes to tobacco products be reported to the FDA and that no changes be allowed until they have been scientifically shown to reduce addiction or harm.


'/>"/>

Contact: Todd Datz
tdatz@hsph.harvard.edu
617-432-3952
Harvard School of Public Health
Source:Eurekalert

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... ... , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the homeopathic ... Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength is ... , Removal of the homeopathic element , Adding their patented ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. ... GlycoMark test throughout the Northeast U.S. , GlycoMark is the only clinically ... GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic excursions, ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: